Cynosure Group LLC bought a new stake in Crocs, Inc. (NASDAQ:CROX – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,539 shares of the textile maker’s stock, valued at approximately $368,000.
A number of other institutional investors have also bought and sold shares of the company. D.A. Davidson & CO. lifted its stake in shares of Crocs by 67.8% in the 3rd quarter. D.A. Davidson & CO. now owns 2,701 shares of the textile maker’s stock valued at $391,000 after purchasing an additional 1,091 shares during the period. FMR LLC lifted its stake in Crocs by 4.8% in the third quarter. FMR LLC now owns 8,907,591 shares of the textile maker’s stock valued at $1,289,908,000 after buying an additional 406,287 shares during the period. Qsemble Capital Management LP boosted its holdings in shares of Crocs by 309.5% during the 3rd quarter. Qsemble Capital Management LP now owns 7,064 shares of the textile maker’s stock worth $1,023,000 after buying an additional 5,339 shares in the last quarter. Hancock Whitney Corp grew its position in shares of Crocs by 67.9% during the 3rd quarter. Hancock Whitney Corp now owns 13,936 shares of the textile maker’s stock worth $2,018,000 after buying an additional 5,636 shares during the period. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of Crocs in the 3rd quarter valued at $980,000. Institutional investors own 93.44% of the company’s stock.
Analyst Ratings Changes
Several research analysts recently issued reports on CROX shares. StockNews.com lowered shares of Crocs from a “buy” rating to a “hold” rating in a research note on Wednesday, October 30th. Williams Trading raised shares of Crocs from a “hold” rating to a “buy” rating and increased their price objective for the stock from $135.00 to $163.00 in a research report on Thursday, August 22nd. Needham & Company LLC began coverage on Crocs in a research report on Friday, November 22nd. They issued a “buy” rating and a $116.00 target price for the company. Guggenheim cut their price target on Crocs from $182.00 to $155.00 and set a “buy” rating on the stock in a report on Wednesday, October 30th. Finally, KeyCorp decreased their price objective on Crocs from $155.00 to $150.00 and set an “overweight” rating for the company in a report on Wednesday, October 30th. Five analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $148.80.
Insider Buying and Selling
In other news, CFO Susan L. Healy acquired 1,000 shares of the stock in a transaction that occurred on Wednesday, November 13th. The shares were acquired at an average cost of $99.70 per share, for a total transaction of $99,700.00. Following the purchase, the chief financial officer now owns 22,652 shares of the company’s stock, valued at approximately $2,258,404.40. The trade was a 4.62 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John B. Replogle bought 2,240 shares of the business’s stock in a transaction on Wednesday, October 30th. The shares were acquired at an average price of $112.60 per share, with a total value of $252,224.00. Following the transaction, the director now directly owns 9,304 shares of the company’s stock, valued at approximately $1,047,630.40. This trade represents a 31.71 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 2.72% of the stock is currently owned by corporate insiders.
Crocs Price Performance
Shares of NASDAQ CROX opened at $105.60 on Friday. The company has a market capitalization of $6.15 billion, a PE ratio of 7.66, a PEG ratio of 1.10 and a beta of 2.01. The company has a quick ratio of 0.90, a current ratio of 1.43 and a debt-to-equity ratio of 0.82. The stock’s 50 day moving average price is $123.20 and its 200-day moving average price is $135.04. Crocs, Inc. has a twelve month low of $85.71 and a twelve month high of $165.32.
Crocs (NASDAQ:CROX – Get Free Report) last announced its quarterly earnings data on Tuesday, October 29th. The textile maker reported $3.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.10 by $0.50. The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.05 billion. Crocs had a return on equity of 49.70% and a net margin of 20.50%. The business’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.25 EPS. On average, equities analysts anticipate that Crocs, Inc. will post 12.93 EPS for the current year.
Crocs Profile
Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.
Featured Articles
- Five stocks we like better than Crocs
- CD Calculator: Certificate of Deposit Calculator
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Calculate Stock Profit
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- The 3 Best Fintech Stocks to Buy Now
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding CROX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crocs, Inc. (NASDAQ:CROX – Free Report).
Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.